abstract |
The invention is engineered to have (a) an immunoconjugate comprising at least one antigen-binding moiety and an effector moiety, and (b) increased effector function, used in an individual in need thereof for the treatment of a disease. A combination of antibodies is provided. Further provided are pharmaceutical compositions comprising the combination and methods of using them. |